Vanguard Personalized Indexing Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$512K Buy
5,333
+402
+8% +$41.2K ﹤0.01% 1380
2026
Q1
$538K Buy
4,931
+1,794
+57% +$171K 0.01% 1268
2025
Q4
$254K Buy
3,137
+4
+0.1% +$344 ﹤0.01% 1603
2025
Q3
$274K Buy
3,133
+434
+16% +$38.8K ﹤0.01% 1541
2025
Q2
$224K Buy
+2,699
New +$226K ﹤0.01% 1577

Other funds holding LMAT

Vanguard Personalized Indexing Management's LMAT Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its LeMaitre Vascular (LMAT) stake by 8.2% in Q2 2026, buying an estimated $41.2K and bringing the position to 5,333 shares worth $512K. The position accounts for ﹤0.01% of the portfolio, ranked #1380.

Vanguard Personalized Indexing Management first reported a position in LMAT in Q2 2025 and has held it in 5 quarters since. The position peaked at $538K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Vanguard Personalized Indexing Management held 5,333 shares of LeMaitre Vascular worth $512K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 402 LeMaitre Vascular shares in Q2 2026, an estimated $41.2K.
  • LeMaitre Vascular made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1380 holding.
  • Vanguard Personalized Indexing Management first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 5 quarters since.
  • Vanguard Personalized Indexing Management's LeMaitre Vascular position peaked at $538K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.